• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Public Health . Overview of SARS-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023:

tetano

Editor, Senior Moderator
Front Public Health


. 2026 Feb 11:14:1738843.
doi: 10.3389/fpubh.2026.1738843. eCollection 2026.
Overview of SARS-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023: the impact of PAHO and COMISCA's collaborative efforts

Sofía Herrera Agüero[SUP] 1 2 [/SUP], Aldo Sosa[SUP] 3 [/SUP], Alexander A Martinez[SUP] 4 5 6 [/SUP], Ambar Moreno[SUP] 4 [/SUP], César Roberto Conde Pereira[SUP] 7 [/SUP], Claudia Gonzalez[SUP] 4 [/SUP], Claudio Soto-Garita[SUP] 1 [/SUP], Daniel Ulate[SUP] 2 [/SUP], Estela Cordero-Laurent[SUP] 1 [/SUP], Hebleen Brenes[SUP] 1 [/SUP], Isaac Miguel Sánchez[SUP] 8 [/SUP], Jairo Mendez-Rico[SUP] 9 [/SUP], Jessica Góndola[SUP] 4 [/SUP], Jose Arturo Molina Mora[SUP] 2 [/SUP], Juliana Leite[SUP] 9 [/SUP], Leticia Franco[SUP] 9 [/SUP], Linda Mendoza[SUP] 7 [/SUP], Lionel Gresh[SUP] 9 [/SUP], Lucia De La Cruz[SUP] 8 [/SUP], Mitzi Castro Paz[SUP] 10 [/SUP], Monica Barahona[SUP] 11 [/SUP], Naomi Iihoshi[SUP] 11 [/SUP], Oris Chavarría[SUP] 4 [/SUP], Priscila Born[SUP] 9 [/SUP], Ruby Melany Aguillón[SUP] 3 [/SUP], Ruth Carolina Vasquez Cordova[SUP] 12 [/SUP], Selene Gonzalez[SUP] 7 [/SUP], Sofia Carolina Alvarado Silva[SUP] 10 [/SUP], Xochitl Sandoval López[SUP] 12 [/SUP], Yvonne Imbert[SUP] 8 [/SUP], Francisco Duarte-Martínez[SUP] 1 [/SUP]


Affiliations
Abstract

This study provides a comprehensive overview of SARS-CoV-2 genomic surveillance in Central America and the Dominican Republic from February 2020 to January 2023, highlighting the collaborative efforts of the Pan American Health Organization (PAHO), and the Council of Ministers of Health of Central America (COMISCA). A total of 26,595 sequences from the GISAID database were analyzed, correlating findings with key events reported by participating entities. The genomic analysis reveals significant co-circulation of variants, with notable lineage diversity observed throughout the pandemic. Variants of concern (VOC) like Alpha, Gamma, Delta and Omicron were identified alongside variants of interest (VOI) like Lambda and Mu. The emergence of recombinant lineages further illustrates the ongoing evolution of the virus and its spread across the region, underscoring the interconnectedness of Central America and the Dominican Republic. The collaborative model facilitated broader sequencing coverage, enabling more extensive surveillance than individual countries could achieve alone. Despite the successes of regional collaborations, challenges remain, particularly regarding sequencing capacity in countries impacted by socioeconomic inequalities. Addressing these gaps is essential to enhance public health responses to current and future pandemics.

Keywords: COVID-19; Central America; SARS-CoV-2; coronavirus; genomic surveillance; regional collaboration.

 
Back
Top Bottom